Michael Crump

Michael Crump

UNVERIFIED PROFILE

Are you Michael Crump?   Register this Author

Register author
Michael Crump

Michael Crump

Publications by authors named "Michael Crump"

Are you Michael Crump?   Register this Author

100Publications

2616Reads

29Profile Views

Monolithic 3D printing of embeddable and highly stretchable strain sensors using conductive ionogels.

Nanotechnology 2019 Sep 23;30(36):364002. Epub 2019 May 23.

Department of Material Science & Engineering, University of Washington, Seattle, WA 98195-2120, United States of America.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1088/1361-6528/ab2440DOI Listing
September 2019

Outcomes of patients with relapsed low-grade lymphoma retreated with rituximab are similar to rituximab naïve patients.

Leuk Lymphoma 2019 Apr 18:1-4. Epub 2019 Apr 18.

c Division of Medical Oncology and Hematology, Department of Medicine , University of Toronto , Princess Margaret Cancer Centre, University Health Network , Toronto , Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1080/10428194.2019.1585837DOI Listing
April 2019

Improving CD20 antibody therapy: obinutuzumab in lymphoproliferative disorders.

Leuk Lymphoma 2019 Mar 22;60(3):573-582. Epub 2019 Jan 22.

a Division of Medical Oncology and Hematology , Princess Margaret Cancer Centre, University of Toronto , Toronto , Canada.

View Article

Download full-text PDF

Source
https://www.tandfonline.com/doi/full/10.1080/10428194.2018.1
Publisher Site
http://dx.doi.org/10.1080/10428194.2018.1498490DOI Listing
March 2019

Significance of treatment response when managing patients with primary central nervous system lymphoma.

Leuk Lymphoma 2019 Feb 3;60(2):349-357. Epub 2018 Jul 3.

d Princess Margaret Hospital and Mt. Sinai Hospital, University of Toronto, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1080/10428194.2018.1474524DOI Listing
February 2019

Assessment of hydrologic vulnerability to urbanization and climate change in a rapidly changing watershed in the Southeast U.S.

Sci Total Environ 2018 Dec 24;645:806-816. Epub 2018 Jul 24.

Mark Twain National Forest, USDA Forest Service, 401 Fairgrounds Road, Rolla, MO 65401, United States of America.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.scitotenv.2018.06.287DOI Listing
December 2018

Spatio-temporal specialization of GABAergic septo-hippocampal neurons for rhythmic network activity.

Brain Struct Funct 2018 Jun 3;223(5):2409-2432. Epub 2018 Mar 3.

Department of Pharmacology, Mansfield Rd, University of Oxford, Oxford, OX1 3QT, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00429-018-1626-0DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5968071PMC
June 2018

Brentuximab Vedotin for Stage III or IV Hodgkin’s Lymphoma.

Authors:
Michael Crump

N Engl J Med 2018 04;378(16):1559-60

Princess Margaret Cancer Centre, Toronto, ON, Canada

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1056/NEJMc1802363DOI Listing
April 2018

Effectiveness and tolerability of first-line autologous stem cell transplant and maintenance rituximab for mantle cell lymphoma.

Bone Marrow Transplant 2018 03 21;53(3):347-351. Epub 2017 Dec 21.

Department of Medical Oncology and Hematology, Princess Margaret Cancer Centre, and Department of Medicine, University of Toronto, Toronto, ON, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/s41409-017-0054-8DOI Listing
March 2018

Bleomycin pulmonary toxicity does not adversely affect the outcome of patients with Hodgkin lymphoma.

Leuk Lymphoma 2017 11 15;58(11):2607-2614. Epub 2017 May 15.

d Medical Oncology and Hematology , Princess Margaret Cancer Centre , Toronto , Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1080/10428194.2017.1307980DOI Listing
November 2017

Nephrotic Syndrome With Cancer Immunotherapies: A Report of 2 Cases.

Am J Kidney Dis 2017 Oct 23;70(4):581-585. Epub 2017 Jun 23.

Division of Nephrology, University Health Network, University of Toronto, Toronto, ON, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1053/j.ajkd.2017.04.026DOI Listing
October 2017

Predicting outcomes after a positive interim FDG-PET scan in advanced Hodgkin's lymphoma.

Authors:
Michael Crump

Lancet Oncol 2017 04 22;18(4):416-418. Epub 2017 Feb 22.

Medical Oncology and Hematology, Princess Margaret Cancer Centre, Toronto M5G 2M9, Canada. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/S1470-2045(17)30085-2DOI Listing
April 2017

Management of Relapsed Diffuse Large B-cell Lymphoma.

Authors:
Michael Crump

Hematol Oncol Clin North Am 2016 Dec;30(6):1195-1213

Division of Medical Oncology and Hematology, Princess Margaret Cancer Centre, 610 University Avenue, Room 5-209, Toronto M5G 2M9, Canada. Electronic address:

View Article

Download full-text PDF

Source
https://linkinghub.elsevier.com/retrieve/pii/S08898588163009
Publisher Site
http://dx.doi.org/10.1016/j.hoc.2016.07.004DOI Listing
December 2016

General Biomarker Recommendations for Lymphoma.

J Natl Cancer Inst 2016 12 16;108(12). Epub 2016 Dec 16.

Department of Laboratory Medicine and Pathology, Mayo Clinic, Scottsdale, AZ (LR), Department of Pathology and Laboratory Medicine, University of North Carolina Medical School, Chapel Hill, NC (YF), Center for Cancer Research, National Cancer Institute, Bethesda, MD (LMS), Department of Medicine, Weill Cornell Medical College, New York, NY (AM), Department of Pathology and Laboratory Medicine, British Columbia Cancer Agency, Vancouver, BC, Canada (RG), Clinical Cancer Research Unit, Princess Margaret Cancer Centre, University of Toronto, Toronto, Ontario, Canada (MC), Coordinating Center for Clinical Trials, National Cancer Institute, Bethesda, MD (LB), Department of Pathology and Microbiology, University of Nebraska Medical Center, Omaha, NE (KF), Department of Pathology and Laboratory Medicine, Cleveland Clinic Foundation, Cleveland, OH (ED), Department of Pathology, City of Hope Medical Center, Duarte, CA (JWCC), Biometrics Research Branch, National Cancer Institute, Bethesda, MD (LM), Department of Medicine, Weill Cornell Medicine, New York, NY (JPL), Department of Medicine, Oncology Division, Washington University, St. Louis, MO (BSK), Clinical Investigations Branch, Cancer Therapy Evaluation Program, National Cancer Institute, Bethesda, MD (RFL), Wilmot Cancer Center and Division of Hematology/Oncology, University of Rochester, Rochester, NY (JWF), Department of Radiology, Mount Sinai Medical Center New York, NY (LK).

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/jnci/djw250DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6080362PMC
December 2016

Randomized, Double-Blind, Phase III Trial of Enzastaurin Versus Placebo in Patients Achieving Remission After First-Line Therapy for High-Risk Diffuse Large B-Cell Lymphoma.

J Clin Oncol 2016 07 23;34(21):2484-92. Epub 2016 May 23.

Michael Crump, Princess Margaret Cancer Centre, Toronto, Ontario; Kerry J. Savage, British Columbia Cancer Agency, Vancouver, British Columbia, Canada; Sirpa Leppä, Helsinki University Hospital Cancer Center, Helsinki, Finland; Luis Fayad, The University of Texas MD Anderson Cancer Center, Houston, TX; Frederick Schnell, Central Georgia Cancer Care, Macon, GA; Robert Rifkin, US Oncology Research Network and Rocky Mountain Cancer Centers, Denver, CO; Lauren Pinter-Brown, University of California at Los Angeles, Santa Monica, CA; Sonali Smith, University of Chicago, Chicago, IL; Eric D. Hsi, Cleveland Clinic, Cleveland, OH; Tuan Nguyen, Peipei Shi, Marjo Hahka-Kemppinen, Don Thornton, and Boris Lin, Eli Lilly and Company, Indianapolis, IN; Brad Kahl, University of Wisconsin, Madison, WI; Thomas Habermann, Mayo Clinic Cancer Research Consortium, Rochester, NY; Je Jung Lee, Chonnam National University Hwasun Hospital, Gwangju, South Korea; Alice Di Rocco, Sapienza University, Rome, Italy; Michinori Ogura, Tokai Central Hospital, Kakamigahara; Kensei Tobinai, National Cancer Center Hospital, Tokyo, Japan; Hans Hagberg, Akademiska Sjukhuset, Onkologkliniken, Uppsala, Sweden; Andreas Mackensen, University of Erlangen, Erlangen; Norbert Schmitz, Asklepios Klinik St Georg, Hamburg, Germany; Fritz Offner, University of Gent, Gent, Belgium; and Su-Peng Yeh, China Medical University Hospital, Taichung, Republic of China.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2015.65.7171DOI Listing
July 2016

Randomized Phase II Trial Comparing Obinutuzumab (GA101) With Rituximab in Patients With Relapsed CD20+ Indolent B-Cell Non-Hodgkin Lymphoma: Final Analysis of the GAUSS Study.

J Clin Oncol 2015 Oct 17;33(30):3467-74. Epub 2015 Aug 17.

Laurie H. Sehn, Centre for Lymphoid Cancer, British Columbia Cancer Agency and the University of British Columbia, Vancouver, British Columbia; Tara Baetz, Queen's University, Kingston General Hospital, Kingston; Rena Buckstein, Sunnybrook Health Sciences Center; Michael Crump, Princess Margaret Hospital, University of Toronto, Toronto, Ontario, Canada; Andre Goy and Luis E. Fayad, John Theurer Cancer Center, Hackensack University Medical Center, Hackensack, NJ; Fritz C. Offner, Institute of Hematology and Medical Oncology, University of Bologna; Pier Luigi Zinzani, Institute of Hematology "Seràgnoli" University of Bologna, Bologna; Giovanni Martinelli, European Institute of Oncology, Milano; Gianluca Gaidano, Amedeo Avogadro University of Eastern Piedmont, Novara, Italy; M. Dolores Caballero, University Hospital of Salamanca, Salamanca, Spain; Ole Gadeberg, Vejle Hospital, Vejle, Denmark; Andrew D. Zelenetz, Memorial Sloan Kettering Cancer Center, New York; Jonathan Friedberg, James P. Wilmot Cancer Center, University of Rochester, Rochester, NY; Branimir Jadkisic, Clinical Hospital Merkur, University of Zagreb, Zagreb, Croatia; Swaminathan Padmanabhan Iyer, Houston Methodist Cancer Center, Weill Cornell Medical College, Houston, TX; Deniz Sahin and Günter Fingerle-Rowson, Roche, Basel, Switzerland; Akiko Chai, Genentech BioOncology, South San Francisco, CA; Oliver Press, Fred Hutchinson Cancer Research Center, Seattle, WA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2014.59.2139DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5087315PMC
October 2015

Clinical characteristics and early treatment outcomes of follicular lymphoma in young adults.

Br J Haematol 2015 Aug 22;170(3):384-90. Epub 2015 Apr 22.

Division of Medical Oncology and Haematology, Princess Margaret Cancer Centre, Toronto, ON, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/bjh.13451DOI Listing
August 2015

Gemcitabine/dexamethasone/cisplatin vs cytarabine/dexamethasone/cisplatin for relapsed or refractory aggressive-histology lymphoma: cost-utility analysis of NCIC CTG LY.12.

J Natl Cancer Inst 2015 Jul 13;107(7). Epub 2015 Apr 13.

Affiliations of authors: Odette Cancer Centre and University of Toronto, Toronto, Ontario, Canada (MCC, KRI, SH, NM); NCIC Clinical Trials Group, Kingston, Ontario, Canada (AEH, YS, NR, LS, AL, BEC, NM); Princess Margaret Cancer Centre, Toronto, Ontario, Canada (MC, VK); Juravinski Hospital and Cancer Centre and McMaster University, Hamilton, Ontario, Canada (JS, CTK, RMM); Queen Elizabeth II Health Sciences Centre and Dalhousie University, Halifax, Nova Scotia, Canada (SC, DM); Cancer Centre of Southeastern Ontario at Kingston General Hospital, Kingston, Ontario, Canada (TB); Cancercare Manitoba, Winnipeg, Manitoba, Canada (DS); Hopital Charles Lemoyne, Montreal, Quebec, Canada (PD).

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/jnci/djv106DOI Listing
July 2015

Incidence of pneumonitis in patients with non-Hodgkin lymphoma receiving chemoimmunotherapy with rituximab.

Leuk Lymphoma 2015 Jun;56(6):1659-64

Division of Medical Oncology and Hematology, Princess Margaret Cancer Centre , Toronto , Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3109/10428194.2014.963075DOI Listing
June 2015

A single institution experience of extranodal natural killer/T cell lymphoma of nasal type.

Leuk Lymphoma 2015 Jan;56(1):80-4

Department of Radiation Oncology, University of Toronto , ON , Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3109/10428194.2014.909039DOI Listing
January 2015

Chemoimmunotherapy resistant follicular lymphoma: predictors of resistance, association with transformation and prognosis.

Leuk Lymphoma 2014 Nov 7;55(11):2502-7. Epub 2014 Mar 7.

Division of Hematology/Oncology, Princess Margaret Cancer Centre, University Health Network , Toronto , Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3109/10428194.2014.885513DOI Listing
November 2014

Randomized comparison of gemcitabine, dexamethasone, and cisplatin versus dexamethasone, cytarabine, and cisplatin chemotherapy before autologous stem-cell transplantation for relapsed and refractory aggressive lymphomas: NCIC-CTG LY.12.

J Clin Oncol 2014 Nov 29;32(31):3490-6. Epub 2014 Sep 29.

Michael Crump, John Kuruvilla, and Vishal Kukreti, Princess Margaret Cancer Centre; Rena Buckstein and Kevin R. Imrie, Odette Cancer Centre and Sunnybrook Health Sciences Centre, Toronto; C. Tom Kouroukis, Jonathan Sussman, and Ralph M. Meyer, Margaret and Charles Juravinski Cancer Centre, Hamilton; Kang Howson-Jan, London Health Sciences Centre, London; Tara Baetz, Cancer Centre of Southeastern Ontario at Kingston General Hospital; Annette E. Hay, Marina S. Djurfeldt, Ralph M. Meyer, Bingshu E. Chen, and Lois E. Shepherd, NCIC Clinical Trials Group, Kingston; Leonard Kaizer, Credit Valley Hospital, Mississauga, Ontario; Stephen Couban and David A. MacDonald, Queen Elizabeth II Health Sciences Centre and Dalhousie University, Halifax, Nova Scotia; Morel Rubinger, Cancercare Manitoba, Winnipeg, Manitoba; Michael Voralia, Saskatoon Cancer Centre, Saskatoon, Saskatchewan; Harold J. Olney, Centre Hospitalier de l'Université de Montréal-Hopital Notre Dame, Montreal, Quebec; A. Robert Turner, Cross Cancer Institute, Edmonton, Alberta, Canada; Massimo Federico, University of Modena and Reggio Emilia, Modena; Nicola Di Renzo, Ospedale Vito Fazzi, Leece, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2013.53.9593DOI Listing
November 2014

Network state-dependent inhibition of identified hippocampal CA3 axo-axonic cells in vivo.

Nat Neurosci 2013 Dec 20;16(12):1802-1811. Epub 2013 Oct 20.

Medical Research Council Anatomical Neuropharmacology Unit, Department of Pharmacology, Oxford University, Oxford, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/nn.3550DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4471148PMC
December 2013

Treatment response and overall outcome of patients with relapsed and refractory peripheral T-cell lymphoma compared to diffuse large B-cell lymphoma.

Leuk Lymphoma 2013 Mar 8;54(3):507-13. Epub 2012 Sep 8.

Division of Medical Oncology and Hematology, Princess Margaret Hospital, Toronto, Ontario, Canada.

View Article

Download full-text PDF

Source
http://www.tandfonline.com/doi/full/10.3109/10428194.2012.71
Publisher Site
http://dx.doi.org/10.3109/10428194.2012.719615DOI Listing
March 2013

Limited-stage mantle cell lymphoma: treatment outcomes at the Princess Margaret Hospital.

Leuk Lymphoma 2013 Feb 10;54(2):261-7. Epub 2012 Sep 10.

Département de Radio-Oncologie, Hôpital Maisonneuve-Rosemont, Montréal, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3109/10428194.2012.711828DOI Listing
February 2013

Role of salvage radiation therapy for patients with relapsed or refractory hodgkin lymphoma who failed autologous stem cell transplant.

Int J Radiat Oncol Biol Phys 2012 Nov 5;84(3):e329-35. Epub 2012 Jun 5.

Department of Radiation Oncology, Princess Margaret Hospital, University of Toronto, Toronto, Ontario, Canada.

View Article

Download full-text PDF

Source
https://linkinghub.elsevier.com/retrieve/pii/S03603016120055
Publisher Site
http://dx.doi.org/10.1016/j.ijrobp.2012.04.007DOI Listing
November 2012

Thymic mucosa-associated lymphoid tissue lymphoma in an adolescent girl.

J Pediatr Hematol Oncol 2012 Oct;34(7):552-5

Department of Paediatrics, Division of Haematology/Oncology, The Hospital for Sick Children, Toronto, ON, Canada.

View Article

Download full-text PDF

Source
http://content.wkhealth.com/linkback/openurl?sid=WKPTLP:land
Publisher Site
http://dx.doi.org/10.1097/MPH.0b013e3182459f0aDOI Listing
October 2012

Impact of rituximab on treatment outcomes of patients with diffuse large b-cell lymphoma: a population-based analysis.

Br J Haematol 2012 Aug 5;158(4):481-8. Epub 2012 Jun 5.

Department of Oncology, Niagara Health System, St Catharines, ON, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/j.1365-2141.2012.09177.xDOI Listing
August 2012

Salvage chemotherapy and autologous stem cell transplant in primary refractory diffuse large B-cell lymphoma: outcomes and prognostic factors.

Leuk Lymphoma 2012 May;53(5):836-41

Division of Medical Oncology and Hematology, Princess Margaret Hospital, Toronto, ON, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3109/10428194.2011.643404DOI Listing
May 2012

A phase 1 study of obinutuzumab induction followed by 2 years of maintenance in patients with relapsed CD20-positive B-cell malignancies.

Blood 2012 May 20;119(22):5118-25. Epub 2012 Mar 20.

British Columbia Cancer Agency Centre for Lymphoid Cancer and the University of British Columbia, Vancouver, BC, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1182/blood-2012-02-408773DOI Listing
May 2012

Hitting the target in MCL.

Authors:
Michael Crump

Blood 2012 May;119(20):4580-1

Princess Margaret Hospital.

View Article

Download full-text PDF

Source
http://www.bloodjournal.org/cgi/doi/10.1182/blood-2012-04-41
Publisher Site
http://dx.doi.org/10.1182/blood-2012-04-417329DOI Listing
May 2012

Autologous stem cell transplantation in follicular lymphoma: a systematic review and meta-analysis.

J Natl Cancer Inst 2012 Jan 21;104(1):18-28. Epub 2011 Dec 21.

Department of Medical Oncology and Hematology, Princess Margaret Hospital, University of Toronto, Toronto, ON, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/jnci/djr450DOI Listing
January 2012

Multiple insulin degrading enzyme variants alter in vitro reporter gene expression.

PLoS One 2011 22;6(6):e21429. Epub 2011 Jun 22.

Department of Neuroscience, Mayo Clinic College of Medicine, Jacksonville, Florida, United States of America.

View Article

Download full-text PDF

Source
http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0021429PLOS
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3120874PMC
November 2011

Thiocyanate-capped nanocrystal colloids: vibrational reporter of surface chemistry and solution-based route to enhanced coupling in nanocrystal solids.

J Am Chem Soc 2011 Oct 9;133(39):15753-61. Epub 2011 Sep 9.

Department of Electrical and Systems Engineering, University of Pennsylvania, Philadelphia, Pennsylvania 19104, United States.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1021/ja206303gDOI Listing
October 2011

Adult ovarian retinoblastoma genomic profile distinct from prior childhood eye tumor.

Arch Ophthalmol 2011 Aug;129(8):1101-4

Division of Hematology/Oncology, The Hospital for Sick Children, Toronto, ON, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1001/archophthalmol.2011.220DOI Listing
August 2011

How I treat relapsed and refractory Hodgkin lymphoma.

Blood 2011 Apr 24;117(16):4208-17. Epub 2011 Jan 24.

Division of Medical Oncology and Hematology, Princess Margaret Hospital, Toronto, ON, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1182/blood-2010-09-288373DOI Listing
April 2011

Different response to salvage chemotherapy but similar post-transplant outcomes in patients with relapsed and refractory Hodgkin's lymphoma.

Haematologica 2010 Sep 11;95(9):1496-502. Epub 2010 May 11.

Division of Medical Oncology and Hematology, Princess Margaret Hospital, 610 University Avenue, Room 5-221, Toronto M5G 2M9, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3324/haematol.2009.019943DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2930950PMC
September 2010

A population-based study of cardiac morbidity among Hodgkin lymphoma patients with preexisting heart disease.

Blood 2010 Sep 1;116(13):2237-40. Epub 2010 Jul 1.

Department of Radiation Oncology, Princess Margaret Hospital, University of Toronto, 610 University Avenue, Toronto, Ontario, Canada.

View Article

Download full-text PDF

Source
http://www.bloodjournal.org/cgi/doi/10.1182/blood-2010-01-26
Publisher Site
http://dx.doi.org/10.1182/blood-2010-01-263764DOI Listing
September 2010

Chronic lymphocytic leukaemia in pregnancy: a case report and literature review.

Obstet Med 2009 Dec 30;2(4):168-9. Epub 2009 Nov 30.

Division of Medical Oncology and Hematology, Princess Margaret Hospital , Toronto, Ontario , Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1258/om.2009.090036DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4989667PMC
December 2009

Secondary breast cancer in Hodgkin's lymphoma survivors.

J Clin Oncol 2009 Sep 10;27(26):4229-31. Epub 2009 Aug 10.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2009.22.9120DOI Listing
September 2009

Management of Hodgkin lymphoma in relapse after autologous stem cell transplant.

Authors:
Michael Crump

Hematology Am Soc Hematol Educ Program 2008 :326-33

Princess Margaret Hospital, University of Toronto, Toronto, Canada.

View Article

Download full-text PDF

Source
http://www.asheducationbook.org/cgi/doi/10.1182/asheducation
Publisher Site
http://dx.doi.org/10.1182/asheducation-2008.1.326DOI Listing
July 2009

Incidence and risk factors for second cancers after autologous hematopoietic cell transplantation for aggressive non-Hodgkin lymphoma.

Leuk Lymphoma 2009 Mar;50(3):380-6

Division of Medical Oncology and Hematology, Princess Margaret Hospital, Toronto, Ontario, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1080/10428190902756578DOI Listing
March 2009

Bisphosphonates and avascular necrosis of the mandible: case report and review of the literature.

J Plast Reconstr Aesthet Surg 2008 6;61(1):94-8. Epub 2006 Sep 6.

Division of Plastic Surgery, University Health Network, University of Toronto, Toronto, Ontario, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.bjps.2006.06.017DOI Listing
April 2008

Salvage therapy for relapsed/refractory diffuse large B cell lymphoma.

Biol Blood Marrow Transplant 2008 Mar;14(3):259-67

Autologous Blood and Marrow Transplant Program, Princess Margaret Hospital, Toronto, Ontario, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.bbmt.2007.11.013DOI Listing
March 2008

Small intestinal B-cell lymphoma in a patient with lymphangiectasia secondary to abdominal lymphangioma.

J Clin Oncol 2008 Feb;26(4):675-8

Division of Hematology Oncology, Hospital for Sick Children, Toronto, Ontario, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2007.14.4311DOI Listing
February 2008